Clinical trials
Recruiting Primary Myelofibrosis trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 2 |
| Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company | 1 |
| Incyte Corporation | 1 |
| Kartos Therapeutics, Inc. | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| University of Birmingham | 1 |
| iOnctura | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 10 |
| Anemia | 2 |
| Polycythemia Vera | 2 |
| Thrombocythemia, Essential | 2 |
| Thrombocytopenia | 2 |
| Hodgkin Disease | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Leukemia, Myelomonocytic, Chronic | 1 |
| Lymphoma, Non-Hodgkin | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.